Ligand Pharma (LGND)

Ligand Pharma (LGND) Stock Price & Analysis


LGND Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$49.43 - $85.70
Previous Close$59.08
Average Volume (3M)93.87K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$219.04M
Total Debt (Recent Filing)$11.67M
Price to Earnings (P/E)40.7
Nov 07, 2023
Dividend YieldN/A
Share Statistics
EPS (TTM)1.45
Shares Outstanding17,355,257
10 Day Avg. Volume126,655
30 Day Avg. Volume93,872
Standard Deviation0.17
Financial Highlights & Ratios
Price to Book (P/B)4.38
Price to Sales (P/S)38.89
Price to Cash Flow (P/CF)-3126.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Price Target Upside97.64% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Ligand Pharma’s price range in the past 12 months?
Ligand Pharma lowest stock price was $49.43 and its highest was $85.70 in the past 12 months.
    What is Ligand Pharma’s market cap?
    Currently, no data Available
    When is Ligand Pharma’s upcoming earnings report date?
    Ligand Pharma’s upcoming earnings report date is Nov 07, 2023 which is in 42 days.
      How were Ligand Pharma’s earnings last quarter?
      Ligand Pharma released its earnings results on Aug 08, 2023. The company reported $1.42 earnings per share for the quarter, beating the consensus estimate of $0.636 by $0.784.
        Is Ligand Pharma overvalued?
        According to Wall Street analysts Ligand Pharma’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Ligand Pharma pay dividends?
          Ligand Pharma pays a Notavailable dividend of $30.01 which represents an annual dividend yield of N/A. See more information on Ligand Pharma dividends here
            What is Ligand Pharma’s EPS estimate?
            Ligand Pharma’s EPS estimate is $0.59.
              How many shares outstanding does Ligand Pharma have?
              Ligand Pharma has 17,355,257 shares outstanding.
                What happened to Ligand Pharma’s price movement after its last earnings report?
                Ligand Pharma reported an EPS of $1.42 in its last earnings report, beating expectations of $0.636. Following the earnings report the stock price went up 5.348%.
                  Which hedge fund is a major shareholder of Ligand Pharma?
                  Among the largest hedge funds holding Ligand Pharma’s share is Fisher Asset Management LLC. It holds Ligand Pharma’s shares valued at 3M.


                    Ligand Pharma Stock Smart Score

                    The Ligand Pharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Ligand Pharma

                    Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.


                    Top 5 ETFs holding LGND

                    Market Value
                    Smart Score
                    Vanguard Total Stock Market ETF
                    Vanguard Health Care ETF
                    Vanguard Russell 3000 ETF
                    SPDR S&P 1500 Value Tilt ETF
                    Invesco S&P US Total Market ESG Tilt Index ETF Trust Units -CAD Hedged-
                    Up to five ETFs with an Outperform Smart Score that hold LGND. The ETFs are listed according to market value of LGND within the ETF

                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Acer Therapeutics
                    Cyclacel Pharmaceuticals
                    Ovid Therapeutics
                    Moleculin Biotech

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis